U.S. Markets closed

Audentes Therapeutics’ Promising Product Pipeline

Kenneth Smith
Audentes Therapeutics’ Promising Product Pipeline

Gene therapy involves repairing or replacing disease-causing genes. Investor interest in gene therapy stocks has remained buoyant throughout 2018. According to Allied Market Research, the gene therapy market is expected to grow at a 33.3% CAGR (compound annual growth rate) to $4.4 billion by 2023.